Annual report pursuant to Section 13 and 15(d)

Basis of Presentation - Additional Information (Detail)

v3.6.0.2
Basis of Presentation - Additional Information (Detail)
$ / shares in Units, shares in Millions
 1 Months Ended 3 Months Ended 12 Months Ended
Apr. 30, 2016
USD ($)
Building
Dec. 31, 2012
USD ($)
ft²
Mar. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
$ / shares
shares
Dec. 31, 2015
USD ($)
$ / shares
shares
Dec. 31, 2014
USD ($)
$ / shares
shares
Oct. 30, 2016
USD ($)
Dec. 31, 2009
Subsidiary or Equity Method Investee [Line Items]                
Deferred income tax expense (benefits)       $ (36,400,000) $ (38,200,000) $ (84,800,000)    
Foreign currency transaction losses       (11,400,000) (34,700,000) (219,000,000)    
Receivables from credit card company       51,800,000 49,300,000      
Bad-debt expense       1,000,000 3,700,000 2,200,000    
Allowance for doubtful accounts       1,300,000 1,500,000      
Amortization expense related to debt issuance costs       7,900,000 8,500,000 6,800,000    
Unamortized debt issuance cost       11,900,000 19,800,000      
Capitalized internal-use software costs       145,700,000 140,200,000      
Depreciation and amortization of property, plant and equipment       80,700,000 82,500,000 81,500,000    
Additions to goodwill or marketing related intangible assets       0 0 0    
Impairments of goodwill or marketing related intangible assets       0 0 0    
Marketing related intangible assets       310,000,000 310,000,000      
Goodwill       89,900,000 91,800,000      
Other operating income       63,800,000 6,500,000      
Arbitration tribunal award in connection with the re-audit of the Company’s 2010 to 2012 financial statements             $ 29,700,000  
Advertising costs       $ 64,800,000 $ 66,100,000 $ 69,700,000    
Equity grants with anti-dilutive effect | shares       4.5 5.4 2.7    
Allowance for product returns       $ 3,900,000 $ 3,900,000 $ 4,300,000    
Product returns       4,500,000 5,000,000 7,300,000    
Non-cash capital expenditures       12,700,000 12,300,000 12,300,000    
Non-cash inflows relating to deposits in escrow         15,000,000      
Non-cash borrowings that were used to finance software maintenance       20,800,000 17,300,000      
Convertible Debt [Member]                
Subsidiary or Equity Method Investee [Line Items]                
Amortization expense related to debt issuance costs       $ 3,800,000 $ 3,200,000 $ 3,300,000    
Convertible notes initial conversion price | $ / shares       $ 86.28 $ 86.28 $ 86.28    
Other Assets [Member]                
Subsidiary or Equity Method Investee [Line Items]                
Long-term deferred tax assets       $ 155,200,000 $ 7,800,000      
Maximum [Member]                
Subsidiary or Equity Method Investee [Line Items]                
Period of receiving anticipated returns       12 months        
North Carolina [Member]                
Subsidiary or Equity Method Investee [Line Items]                
Square footage of facility purchased | ft²   800,000            
Purchase price of facility   $ 22,200,000            
California [Member]                
Subsidiary or Equity Method Investee [Line Items]                
Number of office buildings purchased | Building 1              
Payments to acquire office buildings $ 29,600,000              
Deferred rent liability 1,100,000              
China [Member]                
Subsidiary or Equity Method Investee [Line Items]                
Goodwill       $ 3,100,000 3,300,000      
Other operating income       34,200,000 6,500,000 $ 0    
Venezuela [Member]                
Subsidiary or Equity Method Investee [Line Items]                
Percentage of cumulative inflation rate               100.00%
Foreign currency transaction losses       $ 7,200,000 $ 42,800,000 $ 229,000,000    
Subsidiary's net sales to Company's consolidated net sales, percentage       1.00% 1.00% 3.00%    
Bolivar-denominated cash       $ 800,000 $ 7,700,000      
Subsidiary asset as percentage of consolidated assets       1.00% 1.00%      
Buildings [Member]                
Subsidiary or Equity Method Investee [Line Items]                
Estimated useful life       40 years        
Buildings [Member] | North Carolina [Member]                
Subsidiary or Equity Method Investee [Line Items]                
Property plant and equipment at fair value   18,800,000            
Buildings [Member] | California [Member]                
Subsidiary or Equity Method Investee [Line Items]                
Property plant and equipment at fair value 16,900,000              
Land [Member] | North Carolina [Member]                
Subsidiary or Equity Method Investee [Line Items]                
Property plant and equipment at fair value   $ 3,400,000            
Land [Member] | California [Member]                
Subsidiary or Equity Method Investee [Line Items]                
Property plant and equipment at fair value $ 11,600,000              
Furniture, Fixtures and Equipment [Member] | Minimum [Member]                
Subsidiary or Equity Method Investee [Line Items]                
Estimated useful life       3 years        
Furniture, Fixtures and Equipment [Member] | Maximum [Member]                
Subsidiary or Equity Method Investee [Line Items]                
Estimated useful life       10 years        
Building Improvements [Member] | Minimum [Member]                
Subsidiary or Equity Method Investee [Line Items]                
Estimated useful life       10 years        
Building Improvements [Member] | Maximum [Member]                
Subsidiary or Equity Method Investee [Line Items]                
Estimated useful life       15 years        
Accounting Standards Update 2016-09 [Member] | Scenario Forecast [Member]                
Subsidiary or Equity Method Investee [Line Items]                
Deferred income tax expense (benefits)     $ (29,600,000)